𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Future options for first-line therapy of advanced ovarian cancer

✍ Scribed by A. Du Bois; J Pfisterer

Book ID
109085486
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
323 KB
Volume
15
Category
Article
ISSN
1048-891X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

First-line therapy for advanced colorect
First-line therapy for advanced colorectal cancer
✍ Aimery de Gramont; Christophe Tournigand; Christophe Louvet; FrΓ©dΓ©rique Maindrau πŸ“‚ Article πŸ“… 2005 πŸ› Current Science Inc. 🌐 English βš– 242 KB
Is paclitaxel and cisplatin a cost-effec
Is paclitaxel and cisplatin a cost-effective first-line therapy for advanced ovarian carcinoma?
✍ Allan Covens; Sylvain Boucher; Kathie Roche; Moira Macdonald; Daniel Pettitt; Br πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 567 KB

## BACKGROUND. Paclitaxel and cisplatin use for the treatment of advanced ovarian carcinoma (AOC) has been shown to increase median sunrival duration. An evaluation was performed on the economic consequences of treating AOC patients with combined paclitaxel and cisplatin chemotherapy compared with